Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Lisa M. Niswander"'
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/397ce4a1f83040fdb9cadf2d93cc6504
Autor:
Lisa M. Niswander, Zachary T. Graff, Christopher D. Chien, John A. Chukinas, Christina A. Meadows, Lillie C. Leach, Joseph P. Loftus, M. Eric Kohler, Sarah K. Tasian, Terry J. Fry
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
Chimeric antigen receptor (CAR) T-cell immunotherapies targeting CD19 or CD22 induce remissions in the majority of patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), although relapse due to target antigen loss or downregulat
Externí odkaz:
https://doaj.org/article/a5805048705444a4ba59c1b09eba9327
Autor:
Lisa M. Niswander, Joseph P. Loftus, Élodie Lainey, Aurélie Caye-Eude, Morgane Pondrom, David A. Hottman, Ilaria Iacobucci, Charles G. Mullighan, Nitin Jain, Marina Konopleva, Hélène Cavé, André Baruchel, Pierre S. Rohrlich, Sarah K. Tasian
Publikováno v:
Haematologica, Vol 106, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/311cf5f604d14802a8761c476155a5e8
Autor:
Joseph P. Loftus, Anella Yahiaoui, Patrick A. Brown, Lisa M. Niswander, Asen Bagashev, Min Wang, Allyson Schauf, Stacey Tannheimer, Sarah K. Tasian
Publikováno v:
Haematologica, Vol 106, Iss 4 (2020)
Survival of infants with KMT2A-rearranged (R) acute lymphoblastic leukemia (ALL) remains dismal despite intensive chemotherapy. We observed constitutive phosphorylation of spleen tyrosine kinase (SYK) and associated signaling proteins in infant ALL p
Externí odkaz:
https://doaj.org/article/b6e30a6181114ddcad0ea73e283eeba5
Autor:
Haiying Qin, Nirali N Shah, Terry J Fry, Lila Yang, John A Chukinas, Samiksha Tarun, Marie Pouzolles, Christopher D Chien, Lisa M Niswander, Anthony R Welch, Sarah K Tasian, Naomi A Taylor
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Externí odkaz:
https://doaj.org/article/7341e3e04ef748e4ab7d4e2752aa2b98
Autor:
Morgane Pondrom, Nitin Jain, Marina Konopleva, Sarah K. Tasian, André Baruchel, Aurélie Caye-Eude, Joseph P. Loftus, Ilaria Iacobucci, Lisa M Niswander, Pierre Rohrlich, Charles G. Mullighan, David A Hottman, Elodie Lainey, Hélène Cavé
Publikováno v:
Haematologica. 106:2763-2767
Publikováno v:
Blood. 140:6173-6174
Autor:
Catherine D Falkenstein, Lisa M Niswander, Linda Kessler, Blake Tomkinson, Francis Burrows, Sarah K Tasian
Publikováno v:
Blood. 140:3491-3492
Autor:
Min Wang, Joseph P. Loftus, Lisa M Niswander, Stacey Tannheimer, Patrick A. Brown, Anella Yahiaoui, Sarah K. Tasian, Asen Bagashev, Allyson Schauf
Publikováno v:
Haematologica
Survival of infants with KMT2A-rearranged acute lymphoblastic leukemia (ALL) remains dismal despite intensive chemotherapy. We observed constitutive phosphorylation of spleen tyrosine kinase (SYK) and associated signaling proteins in infant ALL patie
Autor:
Naomi Taylor, Terry J. Fry, Christopher D. Chien, Lila Yang, Sarah K. Tasian, Nirali N. Shah, Haiying Qin, Marie Pouzolles, John Chukinas, Samiksha Tarun, Anthony R. Welch, Lisa M Niswander
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundSuccessful development of chimeric antigen receptor (CAR) T cell immunotherapy for children and adults with relapsed/refractory acute myeloid leukemia (AML) is highly desired given their poor clinical prognosis and frequent inability to ach